Paolo Caraceni
Paolo Caraceni
Verified email at
Cited by
Cited by
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites
P Angeli, P Ginès, F Wong, M Bernardi, TD Boyer, A Gerbes, R Moreau, ...
Gut 64 (4), 531-537, 2015
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
F Conti, F Buonfiglioli, A Scuteri, C Crespi, L Bolondi, P Caraceni, ...
Journal of hepatology 65 (4), 727-733, 2016
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
R Jalan, F Saliba, M Pavesi, A Amoros, R Moreau, P Ginès, E Levesque, ...
Journal of hepatology 61 (5), 1038-1047, 2014
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
F Trevisani, PE D'Intino, AM Morselli-Labate, G Mazzella, E Accogli, ...
Journal of hepatology 34 (4), 570-575, 2001
Systemic inflammation in decompensated cirrhosis: characterization and role in acute‐on‐chronic liver failure
J Clària, RE Stauber, MJ Coenraad, R Moreau, R Jalan, M Pavesi, ...
Hepatology 64 (4), 1249-1264, 2016
Clinical course of acute‐on‐chronic liver failure syndrome and effects on prognosis
T Gustot, J Fernandez, E Garcia, F Morando, P Caraceni, C Alessandria, ...
Hepatology 62 (1), 243-252, 2015
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure
A Kribben, G Gerken, S Haag, S Herget–Rosenthal, U Treichel, C Betz, ...
Gastroenterology 142 (4), 782-789. e3, 2012
Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications
R Garcia‐Martinez, P Caraceni, M Bernardi, P Gines, V Arroyo, R Jalan
Hepatology 58 (5), 1836-1846, 2013
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ...
The Lancet 391 (10138), 2417-2429, 2018
Albumin infusion in patients undergoing large‐volume paracentesis: a meta‐analysis of randomized trials
M Bernardi, P Caraceni, RJ Navickis, MM Wilkes
Hepatology 55 (4), 1172-1181, 2012
Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide
S Piano, V Singh, P Caraceni, R Maiwall, C Alessandria, J Fernandez, ...
Gastroenterology 156 (5), 1368-1380. e10, 2019
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
R Jalan, M Pavesi, F Saliba, A Amorós, J Fernandez, P Holland-Fischer, ...
Journal of hepatology 62 (4), 831-840, 2015
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial
M Cavallin, PS Kamath, M Merli, S Fasolato, P Toniutto, F Salerno, ...
Hepatology 62 (2), 567-574, 2015
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ...
Journal of hepatology 73 (4), 842-854, 2020
Prophylaxis and treatment of hepatitis B in immunocompromised patients
A Marzano, E Angelucci, P Andreone, M Brunetto, R Bruno, P Burra, ...
Digestive and Liver Disease 39 (5), 397-408, 2007
Albumin in decompensated cirrhosis: new concepts and perspectives
M Bernardi, P Angeli, J Claria, R Moreau, P Gines, R Jalan, P Caraceni, ...
Gut 69 (6), 1127-1138, 2020
The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis
V Arroyo, P Angeli, R Moreau, R Jalan, J Clària, J Trebicka, J Fernández, ...
Journal of hepatology 74 (3), 670-685, 2021
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
J Fernández, V Prado, J Trebicka, A Amoros, T Gustot, R Wiest, ...
Journal of hepatology 70 (3), 398-411, 2019
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
R Moreau, J Clària, F Aguilar, F Fenaille, JJ Lozano, C Junot, B Colsch, ...
Journal of hepatology 72 (4), 688-701, 2020
Cardiac electrophysiological abnormalities in patients with cirrhosis
A Zambruni, F Trevisani, P Caraceni, M Bernardi
Journal of hepatology 44 (5), 994-1002, 2006
The system can't perform the operation now. Try again later.
Articles 1–20